The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Clinical observation of pinaverium bromide combined oryzanol in treatment of irritable bowel syndrome
Author(s): 
Pages: 69-70
Year: Issue:  1
Journal: China Modern Medicine

Keyword:  Pinaverium bromideOryzanolIrritable bowel syndromeEffect;
Abstract: Objective:To observe the clinical efficacy of pinaverium bromide and oryzanol in the treatment of irritable bowel syndrome.Methods:58 patients with irritable bowel syndrome were randomly divided into observation group of 30 patients,28 patients in control group.Control group were given pinaverium bromide treatment,three times a day,each 50 mg.Observation group were treated on the basis of another given oryzanol treatment three times a day,each 30 mg.30-day cycle,observed the clinical effect.Results:30 patients observed total number of valid cases 29 cases,accounting for 96.67%,control group 28 patients,the total number of valid cases 20 cases,accounting for 71.43%.The total effective rate was significant difference(χ2=5.24,P<0.05).Observed significant efficiency(56.67%) compared with the control group,differences were statistically significant(χ2=5.99,P<0.05).And all patients had no obvious adverse reactions.Conclusion:Pinaverium bromide and oryzanol combination therapy is significantly effect,relapse,which should be clinical application.
Related Articles
No related articles found